Clinical Trial Update: Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated intravitreal ranibizumab with deferred laser grid photocoagulation for diabetic macular edema with visual impairment and has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED